CLLS(Cellectis S.A.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $30.35M | $19.17M | $755.00K | $41.51M | $72.95M |
| 毛利润 | $28.50M | $17.40M | $18.00K | $41.51M | $72.95M |
| 营业利润 | −$103.48M | −$89.67M | −$97.30M | −$59.55M | −$33.08M |
| 净利润 | −$114.20M | −$106.14M | −$101.06M | −$36.76M | −$67.59M |
| 经营现金流 | −$104.56M | −$87.44M | −$24.75M | $22.99M | −$39.40M |
| 自由现金流 | −$123.11M | −$89.88M | −$25.82M | $20.41M | −$41.76M |
| 摊薄每股收益 | $-2.55 | $-2.33 | $-1.77 | $-0.41 | $-0.67 |